Skip to main content

ALK Inhibitors: Small Molecules and Peptides

Anaplastic Lymphoma Kinase (ALK), also known as CD246, is a 220 kDa transmembrane glycoprotein that is primarily expressed in the developing nervous system. ALK contains one LDL Receptor (LDLR) class A domain, two meprin/A5-protein/PTPmu (MAM) domains, and a cytoplasmic kinase domain. Chromosomal translocation involving ALK and the nucleolar NPM protein result in a cytoplasmic fusion protein that exists as a dimer. The kinase domain in NPM-ALK is constitutively active and participates in cellular transformation. ALK translocations are found in a variety of tumors. Within the extracellular domain, human and mouse ALK share 88% amino acid sequence identity.

Show More

5 results for "ALK Inhibitors Small Molecules and Peptides" in Products

5 results for "ALK Inhibitors Small Molecules and Peptides" in Products

ALK Inhibitors: Small Molecules and Peptides

Anaplastic Lymphoma Kinase (ALK), also known as CD246, is a 220 kDa transmembrane glycoprotein that is primarily expressed in the developing nervous system. ALK contains one LDL Receptor (LDLR) class A domain, two meprin/A5-protein/PTPmu (MAM) domains, and a cytoplasmic kinase domain. Chromosomal translocation involving ALK and the nucleolar NPM protein result in a cytoplasmic fusion protein that exists as a dimer. The kinase domain in NPM-ALK is constitutively active and participates in cellular transformation. ALK translocations are found in a variety of tumors. Within the extracellular domain, human and mouse ALK share 88% amino acid sequence identity.

Show More

Potent c-MET/ALK inhibitor

Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3

Potent anaplastic lymphoma kinase (ALK) inhibitor; also potent ACK inhibitor

Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma kinase (ALK)

A 83-01 synthesized to Ancillary Material Grade

Results Per Page
5 10 25 50
/ 1